Urokinase and its receptor in follicular and inflammatory cysts of the jaws

Oral Diseases

Volumn 16, Issue 8, 2010, Pages 753-759

  Serratì, Simona ^a,b   Panzardi, Irene ^a   Margheri, Francesca ^a,b   Chillà, Anastasia ^a,b   Torre, Eugenio ^a   Fibbi, Gabriella ^a,b   Tonelli, Paolo ^a   Del Rosso, Mario ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Center for the Study at Molecular and Clinical Level of Chronic   (Italy)

Author keywords

Jaw cysts; Protease inhibitors; Proteases; UPA; UPAR

Indexed keywords

CASEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE; UROKINASE RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CYST FLUID; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; JAW CYST; MALE; PRIORITY JOURNAL; ZYMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD45; BLOTTING, WESTERN; CYST FLUID; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; JAW CYSTS; MALE; MIDDLE AGED; ODONTOGENIC CYSTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATORS; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 77958156852     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2010.01679.x     Document Type: Article

References (18)

1. Birkedal-Hansen H (1995). Proteolytic remodelling of extracellular matrix. Curr Opinion Cell Biol 7: 728-735.
2. D'Alessio S, Fibbi G, Cinelli M et al (2004). Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis. Arthritis Rheum 50: 3275-3285.
3. Del Rosso M, Fibbi G, Pucci M, Margheri F, SerratÌ Ì Ì S (2008). The plasminogen activation system in inflammation. Front Biosci 13: 4667-4686.
4. Hoyer-Hansen G, Behrendt N, Ploug M, Dano K, Preissner KT (1997a). The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction. FEBS Lett 420: 79-85.
5. Hoyer-Hansen G, Ploug M, Behrendt N, Ronne E, Dano K (1997b). Cell-surface acceleration of urokinase-catalyzed receptor cleavage. Eur J Biochem 243: 21-26.
6. Kubota Y, Ninomiya T, Oka S, Takenoshita Y, Shirasuna K (2000). Interleukin IL-1-dependent regulation of matrix metalloproteinase-9 (MMP-9) secretion and activation in the epithelial cells of odontogenic jaw cysts. J Dent Res 79: 1423-1430.
7. Li T, Browne RM, Matthews JB (1997). Immunocytochemical expression of parathyroid hormone related protein (PTHrP) in odontogenic jaw cyst. Br J Oral Maxillofac Surg 35: 275-279.
8. Nielsen BS, Sehested M, Duun S et al (2001). Urokinase plasminogen activator is localized in stromal cells in ductal breast cancer. Lab Invest 81: 1485-1501.
9. Ploug M, Ronne E, Behrendt N, Jensen AL, Blasi F, Dano K (1991). Cellular receptor for urokinase plasminogen activator: carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J Biol Chem 266: 1926-1933.
10. Scholl RJ, Kellett HM, Neumann DP, Lurie AG (1999). Cysts and cystic lesions of the mandible: clinical and radiologic - histopathologic review. Radiographics 19: 1107-1124.
11. SerratÌ Ì Ì S, Margheri F, Bruschi S et al (2006). Plasminogen activators and inhibitor-type 1 in alveolar osteitis. Eur J Oral Sci 114: 500-593.
12. Shear M, Speight PM (2007). Cysts of the oral and maxillofacial regions. Blackwell Publishing: Oxford.
13. Stoelinga PJ, Bronkhorst FB (1988). The incidence, multiple presentation and recurrence of aggressive cysts of the jaws. J Craniomaxillofac Surg 16: 184-195.
14. Sugimura M, Kashibayashi Y, Tsubakimoto M, Ban I, Kawakatsu K (1976). Fibrinolytic activity in cystic lesions of jaw bones. Int J Oral Surg 5: 166-171.
15. Tay JY, Bay BH, Yeo JF, Harris M, Meghji S, Dheen ST (2004). Identification of RANKL in osteolytic lesions of the facial skeleton. J Dent Res 83: 349-353.
16. Tsai C-H, Weng S-F, Yang L-C, Huang F-M, Chen Y-J, Chang Y-C (2004). Immunohistochemical localization of tissue-type plasminogen activator and type 1 plasminogen activator inhibitor in radicular cysts. J Oral Pathol Med 33: 156-161.
17. Vassalli J-D, Belin D (1987). Amiloride selectively inhibits the urokinase-type plasminogen activators in the murine kidney. J Clin Invest 87: 962-970.
18. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA (1994). Identification of the urokinase receptor as cell adhesion receptor for vitronectin. J Biol Chem 269: 32380-32388.